153 related articles for article (PubMed ID: 16056252)
1. Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
Valbuena JR; Rassidakis GZ; Lin P; Atwell C; Georgakis GV; Younes A; Jones D; Medeiros LJ
Mod Pathol; 2005 Oct; 18(10):1343-9. PubMed ID: 16056252
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.
Sung CO; Ko YH; Park S; Kim K; Kim W
J Korean Med Sci; 2005 Dec; 20(6):952-6. PubMed ID: 16361803
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand expression in nodal non-Hodgkin's lymphoma.
Müllauer L; Mosberger I; Chott A
Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
[TBL] [Abstract][Full Text] [Related]
9. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of WT1 gene product in non-Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Tsioli P; Lai R; Jones D; Medeiros LJ
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):132-7. PubMed ID: 15894924
[TBL] [Abstract][Full Text] [Related]
11. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.
Canoz O; Rassidakis GZ; Admirand JH; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):911-7. PubMed ID: 15105810
[TBL] [Abstract][Full Text] [Related]
15. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
17. Study of vimentin expression in non-Hodgkin's lymphoma using paraffin sections.
Tamaru J; Mikata A; Itami M; Takagi T
Acta Pathol Jpn; 1990 Jul; 40(7):517-21. PubMed ID: 1699393
[TBL] [Abstract][Full Text] [Related]
18. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
19. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.
Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G
Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666
[TBL] [Abstract][Full Text] [Related]
20. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]